Showing results 257-264 / 1477

Custom pharmaceutical solutions market

Solving the most challenging chemistry and scale-up problems, Johnson Matthey can provide custom pharmaceutical solutions to accelerate innovation.

Explore

Controlled substances market

An insight into our extensive range of controlled substances and opioids, and examples of where our products are used.

Explore

Johnson Matthey Technology Review

Johnson Matthey’s international journal of research exploring science and technology in industrial applications.

Explore

Chemical synthesis

Read about our expertise in chemical synthesis which covers organic, inorganic and organometallic compounds including controlled substances, pharmaceutical ingredients, specialist salts, commodity chemicals and catalysts.

Explore

APIs market

Information on the range of active pharmaceutical ingredients (APIs) produced by Johnson Matthey Fine Chemicals.

Explore

Learning and development

Read about how we'll help you to learn on the job and develop your skills.

Explore

CCS-enabled (blue) hydrogen

Manufacturing CCS-enabled blue hydrogen at scale is an essential early step in reducing global carbon dioxide emissions, enabling the planet to achieve net zero emissions. Our LCH™ technology (using GHR + ATR) delivers the highest process efficiency and lowest LCOH commercially available today.

Explore

Electrolysis (green) hydrogen

As a truly carbon neutral solution, green hydrogen (produced from renewable energy sources using electrolysis) is gaining more attention from governments and industry.

Explore